Merck has made a significant investment in the Thailand-based healthcare startup HD, which operates a digital marketplace called HDmall. This platform aims to streamline the fragmented healthcare industry in Southeast Asia by connecting users with healthcare providers and offering various medical services. With $7.8 million in new funding, HD plans to enhance its marketplace and further develop its AI technology.
The startup's innovative approach includes the implementation of an AI chatbot, Jib AI, which manages a substantial portion of customer interactions. This technology not only improves efficiency but also allows healthcare professionals to focus on patient care. HD's strategy positions it uniquely in the Southeast Asian market, where traditional telehealth models are facing challenges.
• Merck's investment marks its first in a healthtech startup in Asia Pacific.
• HD's AI chatbot Jib AI manages 60% of customer interactions efficiently.
Jib AI is designed to handle customer interactions, improving response times and efficiency.
Generative AI technology is being implemented in HD's marketplace to enhance user experience.
Merck's investment in HD signifies its commitment to advancing healthcare technology in Asia.
AWS collaborates with healthcare companies to develop AI tools for medical applications.
TechCrunch on MSN.com 7month
Channel NewsAsia Singapore 13month
The Manila Times on MSN.com 14month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.